Perinatal Epidermal Growth Factor Signal Perturbation Results in the Series of Abnormal Auditory Oscillations and Responses Relevant to Schizophrenia
Open Access
- 1 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin Open
- Vol. 2 (1)
Abstract
Auditory neurophysiological responses, such as steady-state responses, event-related potential P300/P3, and phase-amplitude coupling, are promising translational biomarkers for schizophrenia, but their molecular underpinning is poorly understood. Focusing on ErbB receptor signals that are implicated in both schizophrenia and auditory processing/cognition, we explored the causal biological links between ErbB signals and these auditory traits with an experimental intervention into rats. We peripherally challenged rat pups with one of the amniotic ErbB ligands, epidermal growth factor (EGF), and characterized its consequence on the series of these auditory electrocorticographic measures. Auditory brainstem responses (ABRs) and cortical ON responses were also assessed under anesthesia to estimate the influence of higher brain regions. An auditory steady-state paradigm revealed attenuation of spectral power and phase synchrony to 40-Hz stimuli in EGF-challenged rats. We observed a reduction in duration mismatch negativity-like potentials and a delay of P3a responses, all of which are relevant to the reported auditory pathophysiological traits of patients with schizophrenia. Moreover, the perinatal EGF challenges resulted in enhanced theta-alpha/beta and theta-gamma coupling within the auditory cortex and changes in ABRs. However, the EGF challenges retained the normal ranges of cortical ON responses, potentially ruling out their fundamental auditory deficits. Perinatal exposure of an ErbB ligand to rats strikingly reproduced the whole series of aberrant auditory responses and oscillations previously reported in patients with schizophrenia. Accordingly, these findings suggest that developmental deficits in ErbB/EGF signaling might be involved in the auditory pathophysiology associated with schizophrenia.Keywords
Funding Information
- Grants-in-Aid for Scientific Research
- Japan Society for the Promotion of Science and Ministry of Education, Culture, Sports, Science and Technology of Japan (19K17084, 18H02950, 18H04062, 18H04938, 18H05429, 18K19495)
- Japan Agency for Medical Research and Development (20gm0810004h)
This publication has 81 references indexed in Scilit:
- Age-related neuronal loss in the cochlea is not delayed by synaptic modulationNeurobiology of Aging, 2011
- Abnormalities of Neuronal Oscillations and Temporal Integration to Low- and High-Frequency Auditory Stimulation in SchizophreniaBiological Psychiatry, 2011
- Schizophrenia susceptibility pathway neuregulin 1–ErbB4 suppresses Src upregulation of NMDA receptorsNature Medicine, 2011
- Common genetic variation in Neuregulin 3 ( NRG3 ) influences risk for schizophrenia and impacts NRG3 expression in human brainProceedings of the National Academy of Sciences, 2010
- Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactionsBrain Research, 2009
- The nicotinic receptor of cochlear hair cells: A possible pharmacotherapeutic target?Biochemical Pharmacology, 2009
- GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophreniaInternational Journal of Neuropsychopharmacology, 2009
- The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and PlasticityNeuron, 2007
- Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the diseaseProceedings of the National Academy of Sciences, 2006
- Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patientsMolecular Psychiatry, 2002